SOCS Proteins, Regulators of Intracellular Signaling

Slides:



Advertisements
Similar presentations
Functions Receptors Signaling Chapter 11
Advertisements

Signal Transduction II Transduction Proteins & Second Messengers.
Books Molecular Cell Biology Lodish
Growth Factors and Enzyme- Linked Receptor Signal Systems Lecture 29BSCI 420/421Nov 8, 2002 “If we have concluded that we are being asked to take senseless.
Interferons Cytokine family important for innate immunity against viruses Three classes of IFNs according to the receptor used Type I IFNs essential for.
Extracellular signal molecule
JAK-STAT Signaling Pathway.
Figure 2. Signaling pathways activated by IL-21.
Free Powerpoint Templates Page 1 Free Powerpoint Templates What is the IL gene family —Creative BioMart.
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.
CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma  André Veillette, Huaijian Guo  Critical Reviews.
STAT3 Michael Patel.
The JAK-STAT signaling system represents a series of reactions that take place when a hormone binds a receptor that uses this system. While the hormone.
The Ob protein (leptin) and the kidney
Leptin receptor functions: When leptin binds to its receptor (LEPR-B) the receptor undergoes a conformational change that activates the receptor-associated.
Sustaining Proliferative Signaling and Evading Growth Suppressors
Nat. Rev. Rheumatol. doi: /nrrheum
Laurent L'homme, PhD, David Dombrowicz, PhD 
Miriam Marqués, Francisco X. Real  European Urology 
CD5: A New Partner for IL-6
Figure 5 Defects in the JAK–STAT signalling pathway
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
Signaling molecules as therapeutic targets in allergic diseases
دکتر مجیری داروساز متخصص فارماکولوژی
Nat. Rev. Rheumatol. doi: /nrrheum
JAK's SOCS: A Mechanism of Inhibition
IL-33 Raises Alarm Immunity Volume 31, Issue 1, Pages 5-7 (July 2009)
Identification of TOR Signaling Complexes
Peter J. Nelson, Thomas O. Daniel  Kidney International 
Hepatitis B “X” gene linked to cellular calcium release
Unit III Information Essential to Life Processes
Janus Kinase Deregulation in Leukemia and Lymphoma
Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders  Caiyi Wang, Zheng Fang, Zesen Zhu, Jing.
A New Twist in Smad Signaling
Volume 46, Issue 5, Pages (June 2012)
Jo-Ellen Murphy, Caroline Robert, Thomas S. Kupper 
Selective Insulin and Leptin Resistance in Metabolic Disorders
Met as a therapeutic target in HCC: Facts and hopes
Steroid hormones: Interactions with membrane-bound receptors
Volume 18, Issue 1, Pages (July 2013)
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer  Thomas Winder, Heinz–Josef.
The RAS/MAPK Axis Gets Stressed Out
Long Noncoding RNA in Hematopoiesis and Immunity
Interleukin-6 participation in pathology of ocular diseases
Proteins Kinases: Chromatin-Associated Enzymes?
Plagiarism and Pathogenesis
Matthew D. Daugherty, Harmit S. Malik  Cell Host & Microbe 
p38δ and PKD1: Kinase Switches for Insulin Secretion
Molecular mechanisms of IgE regulation
SRC and STAT Pathways Journal of Thoracic Oncology
Volume 123, Issue 6, Pages (December 2002)
Signalling links in the liver: Knitting SOCS with fat and inflammation
Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD 
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
The suppressors of cytokine signaling (SOCS) proteins
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases  Jennifer W. Leiding, MD, Lisa.
Cytokine Signaling Modules in Inflammatory Responses
Intercellular Networks Underlying Developmental Decisions
IL-13 receptors and signaling pathways: An evolving web
The new kid on the block(ade) of the IGF-1 receptor
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Figure 2 Signalling downstream of the IL-6 receptor
Jeffrey C Rathmell, Craig B Thompson  Cell 
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Volume 7, Issue 1, Pages 1-11 (July 1997)
TAMpering with Toll-like Receptor Signaling
Cell Signaling by Receptor Tyrosine Kinases
Characterization of the MM.1 human multiple myeloma (MM) cell lines
Successful targeting of ErbB2 receptors—is PTEN the key?
Dendritic Tau in Alzheimer’s Disease
Presentation transcript:

SOCS Proteins, Regulators of Intracellular Signaling X.Peter Chen, Julie A. Losman, Paul Rothman  Immunity  Volume 13, Issue 3, Pages 287-290 (September 2000) DOI: 10.1016/S1074-7613(00)00028-5

Figure 1 Domain Structure of the SOCS Superfamily Proteins The SOCS superfamily can be divided into two subfamilies: the SH2-containing and the non-SH2-containing SOCS proteins. The former, consisting of CIS and SOCS-1 through SOCS-7, all contain a central SH2 domain in addition to a C-terminal SOCS box. Members of the other family contain the SOCS box and protein domains other than SH2 domain and can thus be grouped into several subfamilies based on the domains that they possess: ASB, ankyrin-repeat-containing proteins; WSB, WD-40-containing proteins; SSB, SPRY-domain-containing proteins; Ras-like GTPases contain a GTPase domain. Immunity 2000 13, 287-290DOI: (10.1016/S1074-7613(00)00028-5)

Figure 2 Negative Regulation of Cytokine Signaling by SOCS Proteins Transcription of some SOCS family genes is activated upon cytokine stimulation, which is possibly mediated by the STAT family of transcription factors. Two mechanisms have been proposed for how SOCS proteins, in turn, suppress cytokine signaling: (1) SOCS proteins (e.g., CIS) may bind to phosphorylated tyrosines (represented by a series of pYs) on the cytokine receptors and block recruitment and activation of downstream molecules (e.g., STATs); and (2) SOCS proteins (e.g., SOCS-1) may suppress cytokine signaling by binding and inhibiting tyrosine kinases (e.g., JAK) that are essential for cytokine signaling. Immunity 2000 13, 287-290DOI: (10.1016/S1074-7613(00)00028-5)